> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Biosimilar User Fees
- URL: https://www.fdaweb.com/draft-guide-on-biosimilar-user-fees/
- Published: 2017-11-16T12:00:00.000Z
- Updated: 2026-09-14T23:02:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140154

*Federal Register* notice: FDA has made available a draft guidance entitled “Assessing User Fees Under the Biosimilar User Fee Amendments of 2017.” The document discusses changes in policies and procedures surrounding the user fee assessment and collection for biosimilar manufacturers. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-11-16/pdf/2017-24831.pdf?ref=fdaweb.com).